Biotech

All Articles

F 2G brings up $100M for second attempt to receive new antifungal to market

.After F2G's very first effort to receive a brand-new lesson of antifungal to market was thwarted du...

Moderna targets $1.1 B in R&ampD costs cuts, drops 5 systems amid earnings tensions

.Moderna has pledged to reduce R&ampD costs through $1.1 billion through 2027. The choice to retract...

Sanofi's $80M bet on Pivot dystrophy drug finishes in phase 3 crash

.Merely four months after Sanofi bet $80 million in beforehand money on Pivot Therapeutics' losmapim...

Oncternal assets drains 60% surrounded by discharges, trial firings

.Cancer cells business Oncternal Rehabs is folding all its medical tests and laying off staff, switc...

Roche is keeping out hopes that its own injectable obesity prospect can ultimately show 25% weight-loss in late-stage trial

.Roche is keeping out hopes that its own injectable excessive weight prospect can inevitably show 25...

Novo Nordisk barrages 'impressive' weight reduction result for dual-acting dental drug in early trial

.Novo Nordisk has lifted the top on a period 1 test of its dental amylin and also GLP-1 receptor co-...

AbbVie files suit BeiGene over blood stream cancer cells drug proprietary knowledge

.Only a handful of quick weeks after succeeding an FDA Fast lane tag for its own investigational BTK...

Lilly provides one-two strike along with second tranche of favorable data on weekly the hormone insulin prospect

.Not long after a good records decline for Eli Lilly's efsitora alfa, the Indianapolis-based company...

BridgeBio reduces genetics treatment budget as professional data let down

.BridgeBio Pharma is actually lowering its gene therapy spending plan and also pulling back from the...

GSK submits HSV vaccine wishes after phase 2 stop working, resigning race to Moderna, BioNTech

.GSK's try to develop the very first injection for herpes simplex virus (HSV) has actually ended in ...